Therefore, statins, particularly simvastatin, might play a crucial role in ameliorating the progression of NAFLD, such as hepatic steatosis, inflammation and fibrosis, via regulating microRNA-34a/Sirtuin-1 pathway. The gene discussed is SIRT1; the disease is metabolic dysfunction-associated steatotic liver disease.